Statistical Validation of Traditional Chinese Diagnostic Procedures

Abstract

In recent years, the modernization of traditional Chinese medicine (TCM) for treatment of patients with critical and life-threatening diseases has attracted much attention in the pharmaceutical industry. The modernization of TCM is based on a scientific evaluation of the safety and effectiveness of the TCM in terms of some well-established quantitative instruments. As a result, statistical validation of such an instrument is essential to have an accurate and reliable clinical assessment of the performance of the TCM. Similar to the validation of a typical quality of life instrument, some validation performance characteristics such as validity, reliability, and ruggedness are considered. In this article, a design for validation of a standard quantitative instrument that is commonly employed for diagnosis of a patient's functions and activities, performance, signs and symptoms of disease, and disease status and severity based on Chinese diagnostic practice is proposed. Methods for statistical validation of the standard instrument are derived. A numerical example is given to illustrate the proposed methods for validation of Chinese diagnostic procedures.

Keywords

Validity Reliability Calibration Validation

Get full access to this article

View all access options for this article.

References

Chow

Pong

Chang

. On traditional Chinese medicine clinical trials. Drug Inf J. 2006;40:395–406.

Tse

Chang

Chow

Hsiung

Statistical quality control process for traditional Chinese medicine. J Biopharm Stat. 2006;16:861–874.

Lyden

Jackson

NINDS tPA Stroke Trial Investigators. Underlying structure of the National Institutes of Health Stroke Scale: results of a factor analysis. Stroke. 1999;30:2347–2354.

Liu

Gong

Acupuncture: ancient therapeutics for stroke. Available at: http://www.tcmpage.com/hp_stroke.html.

Chow

Liu

. Statistical Design and Analysis in Pharmaceutical Science. New York: Marcel Dekker; 1995.

Tse

Chow

. On model selection for standard curve in assay development. J Biopharm Stat. 1995;5:285–296.

Chow

On statistical characteristics of quality of life assessment. J Biopharm Stat. 1994;4:1–17.

Chow

Statistical issues in quality of life assessment. J Biopharm Stat. 1996;6:37–48.

Draper

Smith

Applied Regression Analysis. New York: Wiley; 1980.

10.

Lehmann

. Testing Statistical Hypotheses, 2nd ed. New York: Wiley; 1986.

11.

Searle

Casella

McCulloch

. Variance Components. New York: Wiley; 1992.

12.

Williams

. A confidence interval for variance components. Biometrika. 1962;49:278–281.

13.

Prentice

. Surrogate endpoints in clinical trials: definition and operational criteria. Stat Med. 1989;8:431–440.

14.

Freedman

Graubard

Schatzkin

Statistical validation of intermediate endpoints for chronic diseases. Stat Med. 1992;11:167–178.

15.

Buyse

Molenberghs

Criteria for the validation of surrogate endpoints in randomized experiments. Biometrics. 1998;54:1014–1029.

16.

Weir

Walley

. Statistical evaluation of biomarkers as surrogate endpoints: a literature review. Stat Med. 2006;25:183–203.